Compounds > dioscin
Page last updated: 2024-09-03

dioscin and Hepatocellular Carcinoma

dioscin has been researched along with Hepatocellular Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, D; Fang, L; Han, X; Liu, K; Mao, Z; Peng, J; Qi, Y; Sun, H; Xu, L; Xu, Y; Yin, L1
Du, B; Liu, J; Tan, Y; Wu, Y; Wu, Z; Zeng, X; Zhang, G; Zhang, R; Zhang, W; Zhang, X; Zhao, Y1
Bao, YL; Li, YX; Meng, XY; Sun, BT; Wu, Y; Yu, CL; Zheng, LH1

Other Studies

3 other study(ies) available for dioscin and Hepatocellular Carcinoma

ArticleYear
Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage.
    British journal of pharmacology, 2019, Volume: 176, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Carcinoma, Hepatocellular; Cell Line; Cell Survival; Diosgenin; DNA Damage; Glycolysis; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Phosphoric Monoester Hydrolases; Rats, Wistar; RNA, Small Interfering; Tumor Suppressor Protein p53

2019
Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2016, Nov-15, Volume: 23, Issue:12

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Diosgenin; DNA Fragmentation; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53

2016
Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
    European journal of pharmacology, 2011, Mar-05, Volume: 654, Issue:2

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Diosgenin; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, MDR; Genetic Vectors; HEK293 Cells; Hep G2 Cells; Hepatocytes; High-Throughput Screening Assays; Humans; Liver Neoplasms; Plasmids; RNA, Messenger

2011